The Genestra HMF Natogen Probiotic is specially formulated for infants aged 0 to 12 months. The product aids with healthy growth and development, consisting of "a highly-concentrated, ratio-specific combination of "healthy bacteria strains" Lactobacillus acidophilus, Lactobacillus paracasei and Bifidobacterium animalis subsp. lactis, essential to the development and maturation of the newborn's immune and digestive system."
This combination of healthy bacteria also helps protect a baby's immune system from common infections like colds and flus along with the runny nose, fever and cough symptoms often associated with them.
In addition to curbing infections, the Genestra HMF Natogen Probiotic also reduces the risk of bad bacteria buildup that can lead to childhood allergies and helps support healthy digestion patterns.
What's Driving This Trend
- Infant Probiotic Supplements
- Opportunity for developing new probiotic supplements specifically formulated for infants to support healthy growth and development.
- Immune-boosting Probiotics
- Disruptive innovation opportunity to create probiotic products that protect and strengthen the immune system in babies.
- Preventing Childhood Allergies
- Potential for developing probiotic solutions that reduce the risk of bad bacteria buildup and prevent allergies in children.
Who This Affects Most
- Pharmaceuticals
- The pharmaceutical industry can explore creating specialized probiotic formulations for infants to meet the growing demand for natural health solutions for babies.
- Nutrition
- Opportunity for the nutrition industry to develop and market probiotic supplements tailored specifically to support the healthy growth and development of infants.
- Pediatric Healthcare
- Pediatric healthcare providers can integrate probiotic supplementation into their treatment plans to support immune system health and prevent childhood allergies.
